Bristol-Myers to acquire Karuna Therapeutics for $14B



Bristol-Myers Squibb Company will acquire Boston-based biotech company Karuna Therapeutics for $14 billion, The Wall Street Journal reported on Friday.

The pharmaceutical giant based in Princeton is …